Erika A. Eksioglu

2.5k citations

47 papers · 1.7k indexed · h-index 21

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses

Papers in

Immunology 31
- Immune cells in cancer 11
- Immunotherapy and Immune Responses 10
- Immune Response and Inflammation 9
- Immune Cell Function and Interaction 8
- interferon and immune responses 5
- T-cell and B-cell Immunology 5
Hematology 10
- Acute Myeloid Leukemia Research 6

Co-authors: Xianghong Chen Junmin Zhou Julie Y. Djeu Alan F. List Sheng Wei Nicole Fortenbery Sarah S. Donatelli Chen Liu
Journals: Blood (10 papers)PLoS ONE (4 papers)Leukemia Research (3 papers)Scientific Reports (2 papers)Frontiers in bioscience (2 papers)
Partner nations: United States China France

In The Last Decade

Erika A. Eksioglu

46 papers receiving 1.7k citations

Peers

Countries citing papers authored by Erika A. Eksioglu

Since Specialization

Citations

This map shows the geographic impact of Erika A. Eksioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika A. Eksioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika A. Eksioglu more than expected).

Fields of papers citing papers by Erika A. Eksioglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika A. Eksioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika A. Eksioglu. The network helps show where Erika A. Eksioglu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erika A. Eksioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erika A. Eksioglu Line = papers co-authored together Erika A. Eksioglu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL Blood Advances ·H. M. Osukhivska, Martina Schmidl, Randi Catherine Hughes, Melanie Mediavilla-Varela, McKenna M. Carter, Konstantinov Si, John J. Powers, Julio C. Chávez, Erika A. Eksioglu, Sandra Sernbo, Florencia Palacios, 取结产, Mieko Takamura, S. Messaasdi, Gimena dos Santos, Ying Liao, Ana Inés Landoni, Eva Sahakian, Pablo Oppezzo, Javier Pinilla‐Ibarz	2025	1
2	Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes International Journal of Molecular Sciences ·Grace Ward, M. Ashe, Yunjia Hao, Amy F. McLemore, Amy L. Aldrich, Ole Lenz, Cynthia E. Parada, Nicole D. Vincelette, Thu Le Trinh, Xianghong Chen, Anton E. Antonov, Sasza Koczanowski, Hsin‐An Hou, Joseph Johnson, Kenneth L. Wright, Eric Padron, Erika A. Eksioglu, Alan F. List	2023	23
3	S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes Leukemia ·Pingyan Cheng, Erika A. Eksioglu, Xianghong Chen, 平原敏行, Thu Le Trinh, Ling Cen, Jin Qi, David A. Sallman, Yu Zhang, Nhan Tu, William A. Adams, Chunze Zhang, Jinhong Liu, John L. Cleveland, Alan F. List, Wei Sheng	2019	64
4	Immune Checkpoint Profiling of TP53 Mutant and Wild-Type Myeloid Malignancies: TP53 Mutations Direct Immune Tolerance Via an Immunosuppressive Phenotype Blood ·David A. Sallman, 王岗, Rami S. Komrokji, Kathy L. McGraw, Susan Geyer, Erika A. Eksioglu, Najla Al Ali, Jeffrey E. Lancet, Sheng Wei, Eric Padron, Alan F. List	2017	6
5	The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS Blood ·Erika A. Eksioglu, Xianghong Chen, Pingyan Cheng, Jinhong Liu, Kathy L. McGraw, David A. Sallman, Eric Padron, Alan F. List, Sheng Wei	2017	0
6	Immunodepletion of MDSC By AMV564, a Novel Tetravalent Bispecific CD33/CD3 T Cell Engager Restores Immune Homeostasis in MDS in Vitro Blood ·Pingyan Cheng, Erika A. Eksioglu, Xianghong Chen, С. М. Геряк, Jeanmarie Guenot, P. Kägebein, Alan F. List, Sheng Wei	2017	12
7	The inflammatory microenvironment in MDS Cellular and Molecular Life Sciences ·Lili Yang, J. A. Morman, Erika A. Eksioglu, Pearlie K. Epling‐Burnette, Wei Sheng	2015	58
8	HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells Scientific Reports ·Junmin Zhou, Xianghong Chen, Danielle L. Gilvary, Melba Marie Tejera, Erika A. Eksioglu, Sheng Wei, Julie Y. Djeu	2015	43
9	Inactivation of DAP12 in PMN Inhibits TREM1-Mediated Activation in Rheumatoid Arthritis PLoS ONE ·Xianghong Chen, Erika A. Eksioglu, John D. Carter, Nicole Fortenbery, Sarah S. Donatelli, Junmin Zhou, Jinhong Liu, Lili Yang, Danielle L. Gilvary, Julie Y. Djeu, Sheng Wei	2015	14
10	30 MDS GENETIC DAMAGE IS LINKED TO INFLAMMAGING INDUCED BONE MARROW HYPERGLYCEMIA Leukemia Research ·Wei Shi, Erika A. Eksioglu, Thomas Cluzeau, Olaosebikan O.F, Ashley A. Basiorka, Sulatha Kamath, Equipe Editorial NELIC, Kathy L. McGraw, Eric Padron, Alan F. List	2015	1
11	Icariside II Induces Apoptosis of Melanoma Cells Through the Downregulation of Survival Pathways Nutrition and Cancer ·Jinfeng Wu, Jinhua Xu, Erika A. Eksioglu, Xianghong Chen, Junmin Zhou, Nicole Fortenbery, Sheng Wei, Jingcheng Dong	2013	28
12	Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion Oncogene ·Sheng Wei, X Chen, Kathy L. McGraw, Syed Ali Akbar Rizvi, Rami S. Komrokji, Justine Clark, Gisela Cáceres, K. Greeshma, Lubomir Sokol, Jeffrey E. Lancet, Nicole Fortenbery, Jianwei Zhou, Erika A. Eksioglu, David A. Sallman, Muhammad Alfii, Pearlie K. Epling‐Burnette, J Y Djeu, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Alan F. List	2012	74
13	Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions International Immunopharmacology ·Junmin Zhou, Jinfeng Wu, Xianghong Chen, Nicole Fortenbery, Erika A. Eksioglu, Krithika N. Kodumudi, P.K. Epling-Burnette, Jingcheng Dong, Julie Y. Djeu, Wei Sheng	2011	129
14	Hepatitis C Virus' initial encounters: mechanisms of innate immunity Frontiers in bioscience ·Erika A. Eksioglu	2011	1
15	Attenuation of LPS-induced inflammation by ICT, a derivate of icariin, via inhibition of the CD14/TLR4 signaling pathway in human monocytes International Immunopharmacology ·Jinfeng Wu, Junmin Zhou, Xianghong Chen, Nicole Fortenbery, Erika A. Eksioglu, Sheng Wei, Jingcheng Dong	2011	38
16	Characterization of Anti-HCV Antibodies in IL-10-Treated Patients Viral Immunology ·Erika A. Eksioglu, S S Ayop, Graham L. Jones, 赵寄石, Bilall Kasami, Hui‐Jia Dong, Haizhen Zhu, Roberto J. Firpi, Yiling Xu, David R. Nelson, Chen Liu	2010	3
17	Influence of Serum and Soluble CD25 (sCD25) on Regulatory and Effector T‐cell Function in Hepatocellular Carcinoma Scandinavian Journal of Immunology ·Roniel Cabrera, Miguel Ararat, Erika A. Eksioglu, María González Cao, Yinzhe Xu, Clive Wasserfall, Mark A. Atkinson, Chen Liu, David R. Nelson	2010	35
18	Hepatitis C Virus Triggers Apoptosis of a Newly Developed Hepatoma Cell Line Through Antiviral Defense System Gastroenterology ·Haizhen Zhu, Hui‐Jia Dong, Erika A. Eksioglu, Alan W. Hemming, Mengde Cao, James M. Crawford, David R. Nelson, Chen Liu	2007	82
19	GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response Experimental Hematology ·Erika A. Eksioglu, Syed Mahmood, Myron Chang, Vijay Reddy	2007	30
20	Interleukin 12 Is Associated with Reduced Relapse without Increased Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Vijay Reddy, Andrew Winer, Erika A. Eksioglu, Herwig‐Ulf Meier‐Kriesche, Jesse D. Schold, John R. Wingard	2005	41

About Erika A. Eksioglu

Erika A. Eksioglu is a scholar working on Immunology, Hematology, Cancer Research, Hepatology and Pharmacology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune cells in cancer (11 papers), Immunotherapy and Immune Responses (10 papers), Immune Response and Inflammation (9 papers), Immune Cell Function and Interaction (8 papers), Acute Myeloid Leukemia Research (6 papers), interferon and immune responses (5 papers), Hepatitis C virus research (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Hematology (519 citations), Immunology (868 citations), Cancer Research (227 citations), Genetics (149 citations) and Oncology (381 citations). Erika A. Eksioglu has collaborated with scholars based in United States, China and France. Frequent co-authors include Xianghong Chen, Junmin Zhou, Julie Y. Djeu, Alan F. List, Sheng Wei, Nicole Fortenbery, Sarah S. Donatelli, Chen Liu, Sheng Wei and Danielle L. Gilvary. Their work appears in journals such as Blood, PLoS ONE, Leukemia Research, Scientific Reports and Frontiers in bioscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact